Predictors of sentinel lymph node mapping failure in endometrial cancer: a retrospective multicenter study
Frontiers in Oncology · 07.04.2026 · 16
DOI: 10.3389/fonc.2026.1799692 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 07.04.2026. Verfasst von Tomas Rokos und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Jessenius Faculty of Medicine in Martin Comenius University in Bratislava (JFMCU), Martin, Slovakia. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This study evaluated risk factors for indocyanine green (ICG) sentinel lymph node (SLN) mapping failure in endometrial cancer patients and assessed their value in predicting SLN mapping failure at the individual patient level.
Methods
We conducted a retrospective study of endometrial cancer patients who underwent ICG-guided SLN biopsy. Risk factors for SLN mapping failure were identified using univariate and multivariate logistic regression analyses. Additionally, an imbalanced random forest (RF) algorithm was trained to predict SLN mapping success or failure. Predictive modeling was used to complement traditional statistical inference by translating population-level associations into patient-specific risk estimates.
Results
A total of 190 patients were included, of whom 35 experienced SLN mapping failure. Univariate analyses showed that age 65 years and over (OR = 2.87, 95% CI 1.31–6.26; p = 0.007) and serous histological subtype (OR = 4.12, 95% CI 1.41–12.0; p = 0.006) were significantly associated with mapping failure. Multivariate analysis revealed that only age remained statistically significant (OR = 1.07 per year; 95% CI 1.02–1.13; p = 0.006). No significant associations were observed for obesity, morbid obesity, tumor grade, or FIGO stage. The discriminative ability of the RF model was poor (cross-validated AUC = 0.58, 95% CI 0.47–0.69).
Conclusion
We suggest—on average—age 65 years and over and a serous histological subtype are risk factors for SLN mapping failure. However, the presence of these risk factors in an individual patient does not reliably predict SLN mapping failure. Additionally, more specific predictors may be needed for accurate individualized prediction.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, Jessenius Faculty of Medicine in Martin Comenius University in Bratislava (JFMCU), Martin, Slovakia.
- Laboratory of Bioinformatics and Biostatistics, Biomedical Center Martin (BIOMED), Jessenius Faculty of Medicine in Martin Comenius University in Bratislava (JFMCU), Martin, Slovakia.
- Department of Obstetrics and Gynecology, Nemocnice Pardubického kraje a.s., Pardubice, Czechia.
- Department of Pathological Anatomy, Jessenius Faculty of Medicine in Martin Comenius University in Bratislava (JFMCU), Martin, Slovakia.
Zitieren
APA
Rokos, T., Grendar, M., Gobel, J., Kotulova, L., Kudela, E., Pribulova, T., Kozubik, E., Kalman, M., & Biringer, K. (2026). Predictors of sentinel lymph node mapping failure in endometrial cancer: a retrospective multicenter study. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1799692
Vancouver
Rokos T, Grendar M, Gobel J, Kotulova L, Kudela E, Pribulova T, et al. Predictors of sentinel lymph node mapping failure in endometrial cancer: a retrospective multicenter study. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1799692
BibTeX
@article{Rokos2026,
author = {Rokos, Tomas and Grendar, Marian and Gobel, Jindrich and Kotulova, Lucia and Kudela, Erik and Pribulova, Terezia and Kozubik, Erik and Kalman, Michal and Biringer, Kamil},
title = {Predictors of sentinel lymph node mapping failure in endometrial cancer: a retrospective multicenter study},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1799692}
}
EUVIMED